Worldwide CRISPR patent landscape shows strong geographical biases

Advancing biotechnology with CRISPR/Cas9: recent applications and patent landscape

(2018) Raphael Ferreira et al.   JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY

EPO revokes Broad's CRISPR patent

(2018) Charlotte Harrison   NATURE BIOTECHNOLOGY

CRISPR plants now subject to tough GM laws in European Union

(2018) Ewen Callaway   NATURE

Use the patent system to regulate gene editing

(2018) Shobita Parthasarathy   NATURE

Evidence of insufficient quality of reporting in patent landscapes in the life sciences

(2017) James A Smith et al.   NATURE BIOTECHNOLOGY

Editing EU legislation to fit plant genome editing

(2016) Agnes E Ricroch et al.   EMBO REPORTS

The emerging patent landscape of CRISPR–Cas gene editing technology

(2016) Knut J Egelie et al.   NATURE BIOTECHNOLOGY

Chimeric Antigen Receptor T-Cell Therapy for the Community Oncologist

(2016) Marcela V. Maus et al.   ONCOLOGIST

The Potential of the Combination of CRISPR/Cas9 and Pluripotent Stem Cells to Provide Human Organs from Chimaeric Pigs

(2015) Wanyou Feng et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Analyzing the impact of the European unitary patent system on worldwide biotechnology

(2014) Ignacio Belda et al.   TRENDS IN BIOTECHNOLOGY

RNA-Guided Human Genome Engineering via Cas9

(2013) P. Mali et al.   SCIENCE

Multiplex Genome Engineering Using CRISPR/Cas Systems

(2013) L. Cong et al.   SCIENCE

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

(2012) M. Jinek et al.   SCIENCE